![](/img/cover-not-exists.png)
Randomized, Phase II Study of the Insulin-Like Growth Factor-1 Receptor Inhibitor IMC-A12, With or Without Cetuximab, in Patients With Cetuximab- or Panitumumab-Refractory Metastatic Colorectal Cancer
Reidy, D. L., Vakiani, E., Fakih, M. G., Saif, M. W., Hecht, J. R., Goodman-Davis, N., Hollywood, E., Shia, J., Schwartz, J., Chandrawansa, K., Dontabhaktuni, A., Youssoufian, H., Solit, D. B., Saltz,Volume:
28
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2010.30.4154
Date:
September, 2010
File:
PDF, 243 KB
english, 2010